Wendel Bruce insider trades

Wendel Bruce has filed 6 Form 4s with the SEC that we hold, for GT Biopharma, Inc. (GTBP) (Director), ImmunityBio, Inc. (IBRX) (Director) and PDS Biotechnology Corp (PDSB) (Director). Across all of them we count 3 purchases worth $26.3K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 1,374 shares of GT Biopharma, Inc. worth $12.2K, dated 2020-12-22. The first filing on our record is dated 2021-10-07 and the latest 2026-10-20.

GT Biopharma, Inc. (GTBP)

Director · 3 filings · 3 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2020-11-16	P, purchase reported on Form 4	3,268	$10.3K	2021-10-07	SEC
2020-12-22	P, purchase reported on Form 4	441	$3.8K	2021-10-07	SEC
2020-12-22	P, purchase reported on Form 4	1,374	$12.2K	2021-10-07	SEC

ImmunityBio, Inc. (IBRX)

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

PDS Biotechnology Corp (PDSB)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1364846) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms